Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
about
Temozolomide for high grade gliomaTemozolomide for High Grade GliomaThe use and impact of quality of life assessment tools in clinical care settings for cancer patients, with a particular emphasis on brain cancer: insights from a systematic review and stakeholder consultations.Supportive management of patients with brain tumors.Longitudinal quality of life data: a comparison of continuous and ordinal approaches.Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings.Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group sTemozolomide: a milestone in neuro-oncology and beyond?Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.Impairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma.Health-related quality of life in glioma patients in China.Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stagesCognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.Measuring symptoms as a critical component of drug development and evaluation in hematological diseasesAssessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients.The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China.Palliative care and quality of life in neuro-oncology.Insomnia among brain tumor patients: a population-based prospective study of tumor patients in northern Finland.Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerationsPrevalence and predictors of fatigue in glioblastoma: a prospective studySymptoms and problems in the end-of-life phase of high-grade glioma patientsHealth-related quality of life and cancer clinical trials.Culturally and linguistically diverse patient participation in glioma research.Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials.Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.Extended adjuvant temozolomide with cis-retinoic acid for adult glioblastoma.Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas.Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.Mechanisms that contribute to the tendency to continue chemotherapy in patients with advanced cancer. Qualitative observations in the clinical settingBlood-brain barrier and chemotherapeutic treatment of brain tumors.Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma.The economics of temozolomide in brain cancer.New developments in the treatment of malignant gliomas.Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and painInsomnia and its associations in patients with recurrent glial neoplasms.Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical articleEnd-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: a questionnaire-based survey.
P2860
Q24197645-C803FE01-76BB-45BE-A06C-07C3ABD4E418Q24241222-C72CDF1A-5E76-4983-92C0-FAF660089EDCQ27314546-095D51C8-CE13-4A09-94B2-FE9E19AF82B8Q30444752-8430DEB1-3ACA-478C-9EF6-4B9F420710C8Q30829260-CE75A878-6C26-461B-9F27-94762B739CD5Q30829434-1B59400D-FAC8-4580-B51A-8666ED9EFC42Q30840511-4709EF4C-8848-4A32-9D34-E52FF7D5BFE2Q31117641-0AAE2AC0-CE4A-4C58-8CAA-ED06CE31D5D5Q33372340-B9B9A23B-F46A-4CEA-9A67-214625F1A31EQ33377752-F47EC66C-C5E9-4E86-8FC3-90DEF04971A3Q33594936-0EFFDB3E-C8AE-4221-8D64-9A5808379207Q33611220-EF94713E-814B-4969-9DA9-F9E32C30E076Q33618760-800AC2A1-3BD5-4552-8622-9BCDD700A382Q33621347-858B7A33-B46C-4B4F-A88C-F9677C6C91A8Q33705743-DB9FE7A6-3C8D-445B-892E-94607D5B2C01Q33797398-3318CFAC-E0CC-4E9D-B617-A4537C75389AQ33806752-C1A9FA7C-353B-458C-AF07-F4092DEAAA79Q33879843-C50AC3A8-B626-4C3C-A4B0-DD43C1F6BFBCQ34019937-09D19A1D-1200-48D6-BAD6-A65962933924Q34369075-B4743733-93EC-48E6-B8F9-4CB4F02EBD40Q34418437-087264D9-43B4-45ED-8487-44B6D833686DQ34886706-BEA82297-8D5F-4727-849E-75DAF9CD1C31Q34992499-A59DF7F4-FEAE-4B0E-B411-F3E7958C7490Q35076356-70CAD8AF-380A-4E0D-90B3-DEF92503482CQ35206198-92B4D78F-A8D3-4AB4-AB42-8483023BD6B4Q35206236-4A25E044-E7FB-43A7-9BFA-08643883C9C2Q35234429-0C00F94F-59D7-4CB4-BA0A-C54899963D7BQ36416218-4B57ABF9-FBE4-4CF1-B7DF-B00E70037E2BQ36478643-C4FD2B7E-1722-4763-8E68-CF9C7D1349E4Q36500074-F40D1E1D-9429-47D8-9037-FE6B9E14F317Q36510951-8E26866C-2355-4F3C-A15B-EA1FA08DB499Q36558683-4651DD39-CF3D-4A9E-9B52-7681B8975C59Q36668246-2FE7E312-2773-42B9-A249-166684F63275Q36877051-1C047A38-183D-48A7-BF0F-C166B9A11E31Q36909282-3DC24EBB-21AE-4686-A239-F3A98D5568DCQ36972696-1A45376D-D534-4C5C-94F6-46816A9C423EQ36980982-B294F926-03D3-422B-8B3F-FE123ED4B8DDQ37026740-72200043-4B13-436A-9CDB-0E124EEFC1EEQ37052309-EDA7D9EC-FE97-4A51-A3D8-156DA91E2CEFQ37109259-BDE5D7AF-1C56-4195-BEED-DC109A1F6930
P2860
Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Health-related quality of life ...... a randomised controlled trial.
@en
type
label
Health-related quality of life ...... a randomised controlled trial.
@en
prefLabel
Health-related quality of life ...... a randomised controlled trial.
@en
P2093
P1433
P1476
Health-related quality of life ...... a randomised controlled trial.
@en
P2093
Brigitta G Baumert
Corneel Coens
David Osoba
EORTC Radiotherapy Group
Elizabeth Eisenhauer
European Organisation for Research and Treatment of Cancer Brain Tumour Group
Martin J B Taphoorn
Martin J van den Bent
Peter Forsyth
René O Mirimanoff
P304
P356
10.1016/S1470-2045(05)70432-0
P577
2005-12-01T00:00:00Z